Prelude Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $679K | Buy |
+4,975
| New | +$611K | 0.05% | 413 |
|
|
2024
Q4 | – | Sell |
-1,790
| Closed | -$266K | – | 1502 |
|
|
2024
Q3 | $266K | Buy |
+1,790
| New | +$257K | 0.02% | 928 |
|
|
2024
Q1 | – | Sell |
-3,920
| Closed | -$705K | – | 1498 |
|
|
2023
Q4 | $705K | Buy |
+3,920
| New | +$610K | 0.05% | 396 |
|
|
2023
Q2 | – | Sell |
-2,365
| Closed | -$398K | – | 1310 |
|
|
2023
Q1 | $398K | Buy |
2,365
+15
| +0.6% | +$2.68K | 0.02% | 538 |
|
|
2022
Q4 | $398K | Buy |
+2,350
| New | +$426K | 0.02% | 664 |
|
|
2022
Q1 | – | Sell |
-2,579
| Closed | -$683K | – | 2157 |
|
|
2021
Q4 | $683K | Sell |
2,579
-293
| -10% | -$78.9K | 0.02% | 832 |
|
|
2021
Q3 | $830K | Sell |
2,872
-60
| -2% | -$15.4K | 0.02% | 648 |
|
|
2021
Q2 | $585K | Buy |
+2,932
| New | +$569K | 0.02% | 865 |
|
|
2021
Q1 | – | Sell |
-1,162
| Closed | -$223K | – | 1773 |
|
|
2020
Q4 | $223K | Buy |
+1,162
| New | +$211K | 0.01% | 1057 |
|
|
2019
Q4 | – | Sell |
-162
| Closed | -$12K | – | 2187 |
|
|
2019
Q3 | $12K | Sell |
162
-11
| -6% | -$962 | ﹤0.01% | 1472 |
|
|
2019
Q2 | $15K | Buy |
173
+128
| +284% | +$8.72K | ﹤0.01% | 1334 |
|
|
2019
Q1 | $3K | Sell |
45
-64
| -59% | -$3.68K | ﹤0.01% | 1671 |
|
|
2018
Q4 | $6K | Buy |
+109
| New | +$6.39K | ﹤0.01% | 1561 |
|
|
2016
Q3 | – | Sell |
-4,258
| Closed | -$116K | – | 1779 |
|
|
2016
Q2 | $116K | Buy |
4,258
+2,358
| +124% | +$60.3K | 0.02% | 699 |
|
|
2016
Q1 | $51K | Sell |
1,900
-600
| -24% | -$14.7K | 0.01% | 969 |
|
|
2015
Q4 | $71K | Buy |
2,500
+600
| +32% | +$17.3K | 0.01% | 942 |
|
|
2015
Q3 | $53K | Buy |
1,900
+400
| +27% | +$14.5K | 0.01% | 1047 |
|
|
2015
Q2 | $62K | Buy |
+1,500
| New | +$55K | 0.01% | 1075 |
|
|
2015
Q1 | – | Sell |
-7,700
| Closed | -$200K | – | 2132 |
|
|
2014
Q4 | $152K | Buy |
7,700
+500
| +7% | +$11.2K | 0.02% | 819 |
|
|
2014
Q3 | $143K | Sell |
7,200
-5,555
| -44% | -$117K | 0.02% | 873 |
|
|
2014
Q2 | $291K | Buy |
12,755
+8,914
| +232% | +$159K | 0.04% | 582 |
|
|
2014
Q1 | $49K | Buy |
+3,841
| New | +$55.1K | 0.01% | 1314 |
|
|
2013
Q4 | – | Sell |
-3,700
| Closed | -$41K | – | 1857 |
|
|
2013
Q3 | $41K | Buy |
+3,700
| New | +$36.8K | 0.01% | 963 |
|
Other funds holding RGEN
UCFA
MC
WA
Prelude Capital Management's RGEN Position: Q2 2026 in Review
Prelude Capital Management opened a new position in Repligen (RGEN) in Q2 2026: 4,975 shares worth $679K. The stake represents 0.05% of the portfolio and ranks #413 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in RGEN as recently as Q3 2024.
Prelude Capital Management first reported a position in RGEN in Q3 2013 and has held it in 23 quarters since. The position peaked at $830K in Q3 2021. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Prelude Capital Management held 4,975 shares of Repligen worth $679K as of Q2 2026.
- Repligen was a new Prelude Capital Management position in Q2 2026.
- Repligen made up 0.05% of Prelude Capital Management's portfolio in Q2 2026, its #413 holding.
- Prelude Capital Management first reported a position in Repligen in Q3 2013 and has held it in 23 quarters since.
- Prelude Capital Management's Repligen position peaked at $830K in Q3 2021.
- 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.